omniture
logo
Search
合源生物科技（天津）有限公司
Media Room

Latest News

rss

Inaticabtagene Autoleucel (YORWIDATM) New Drug Application for Lymphoma Approved, China's innovative CAR-T Enters a New Era of Dual Indications

BEIJING, Nov. 28, 2025 /PRNewswire/ -- On November 28, 2025, Juventas Cell Therapy Co., Ltd. (herei...

2025-11-28 20:52 613